Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Effectiveness and Durability of Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China

NCT06830499 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06830499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06830499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Effectiveness and Durability of Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 24, 2025
Completion date
June 30, 2031
Enrollment
450 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve diseases, bicuspid aortic valve (bav)